Tesla (TSLA)
(Delayed Data from NSDQ)
$197.49 USD
-2.51 (-1.26%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $197.80 +0.31 (0.16%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$197.49 USD
-2.51 (-1.26%)
Updated Aug 12, 2024 04:00 PM ET
After-Market: $197.80 +0.31 (0.16%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Zacks News
Over the years, electric vehicle (‘EV’) maker Tesla has evolved into a dynamic technology innovator. It has transformed the EV market much the same way as Amazon changed the retail landscape and Netflix revolutionized entertainment. Tesla is the market leader in battery-powered electric car sales in the United States, owning around 60% of market share. In fact, the company’s flagship Model 3 accounts for about half of the U.S. EV market. Tesla, which has managed to garner the reputation of a gold standard over the years, is now a far bigger entity that what it started off since its IPO in 2010, with a market capitalization almost double the combined value of top two U.S. auto giants General Motors and Ford.
Top Research Reports for Tesla, Zoetis, Target
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Tesla (TSLA), Zoetis (ZTS) and Target (TGT).
Carmakers Looking Beyond Extended Factory Closures
by Ritujay Ghosh
Many U.S. carmakers are now looking at resuming production in May after President Trump last week extended the guidelines aimed at containing the spread of the coronavirus till Apr 30.
Genuine Parts Scraps '20 Guidance Amid Coronavirus Crisis
by Zacks Equity Research
Genuine Parts (GPC) withdraws 2020 guidance amid significant deterioration of the macro-economic environment triggered by the coronavirus pandemic.
Auto Stock Roundup: TSLA Q1 Deliveries, KMX Earnings & Other Updates
by Zacks Equity Research
While most of the automakers are reeling under the effects of COVID-19 pandemic, Tesla's (TSLA) Q1 deliveries remain robust and CarMax (KMX) posts a comprehensive beat in fourth-quarter fiscal 2020.
Here's What AutoNation is Doing to Fight Coronavirus Crisis
by Zacks Equity Research
AutoNation (AN) furloughing 7,000 employees, slashing executive pay and imposing hiring freeze due to decline in sales amid coronavirus crisis.
Tesla (TSLA) Q1 Deliveries Impress Despite Coronavirus Crisis
by Zacks Equity Research
Tesla's (TSLA) Model S/X division records production and delivery volume of 15,390 and 12,200 vehicles, respectively, in Q1.
ETFs to Ride High on Tesla's Robust Q1 Delivery Numbers
by Sweta Killa
The solid deliveries data has put the spotlight on ETFs having substantial allocation to the luxury carmaker.
Autoliv Taps Brakes on Dividend Payout, Withdraws '20 View
by Zacks Equity Research
Autoliv (ALV) to draw down the remaining $600 million from its existing credit line to combat the coronavirus crisis.
3 Must-Buy Stocks as Coronavirus Cases Spike (Revised)
by Zacks Equity Research
COVID-19 has increased the demand for ventilators and personal protective equipment, which can aid these three companies at large.
Is BorgWarner's $3.3B Buyout of Delphi Technologies at Risk?
by Zacks Equity Research
BorgWarner (BWA) issues notice to Delphi after the latter violates agreement by drawing down its full $500-million revolving credit facility.
The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla
The Zacks Analyst Blog Highlights: General Motors, Tesla, Cardinal Health, ResMed and Medtronic
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Motors, Tesla, Cardinal Health, ResMed and Medtronic
Coronavirus Rampage Continues: 2020 Detroit Auto Show Nixed
by Rimmi Singhi
The Detroit show, officially known as the North American International Auto Show (NAIAS), is now set to be held in June 2021.
CNH Industrial Shuts American Plants, Withdraws 2020 View
by Zacks Equity Research
CNH Industrial (CNHI) withdraws 2020 guidance amid significant deterioration of the macro-economic environment triggered by the coronavirus outbreak.
Here's What Penske is Doing to Fight Coronavirus Crisis
by Zacks Equity Research
Penske (PAG) enforces proactive measures, including cost cuts, staffing-level adjustments and postponement of an estimated $150 million in capital expenditures to combat the coronavirus crisis.
3 Must-Buy Stocks as Coronavirus Cases Spike
by Zacks Equity Research
COVID-19 has increased the demand for ventilators and personal protective equipment, which can aid these three companies at large.
Auto Stock Roundup: Coronavirus-Related Updates Spell Shakeout for the Sector
by Zacks Equity Research
Check out the actions taken by various carmakers in the wake of coronavirus crisis.
General Motors, Ventec Life Team Up to Fight Coronavirus Crisis
by Zacks Equity Research
General Motors (GM) will manufacture VOCSN critical-care ventilators at its Indiana manufacturing facility, including the FDA-cleared ventilators scheduled for shipment as early as next month.
Top Analyst Reports for Alphabet, Procter & Gamble & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet (GOOGL), Procter & Gamble (PG) and Philip Morris International (PM).
Ford (F) Unites With 3M & GE Healthcare to Combat Coronavirus
by Zacks Equity Research
Ford (F) will leverage its manufacturing and engineering resources to increase the production of medical equipment and materials for healthcare staff, first responders and COVID-19 patients.
Join the Wall Street Rally With Industrial ETFs
by Sanghamitra Saha
The industrial sector contributed to the colossal rally at Wall Street on Mar 24 on the hopes of deal wins and a slew of good news from the space.
Ford Suspends Production at IMG Sites on Coronavirus Scare
by Zacks Equity Research
Ford (F) temporarily suspends vehicle and engine production at its manufacturing sites in India, Vietnam, Thailand and South Africa amid coronavirus concerns.
Auto Bigwigs Shift Gears to Ventilators Amid Coronavirus Woes
by Rimmi Singhi
As ventilator makers scramble to meet demand, auto biggies like General Motors, Tesla and others are lending a hand in the fight against COVID-19 pandemic.
Cummins Temporarily Closes Indiana Plant, Withdraws '20 View
by Zacks Equity Research
Cummins (CMI) withdraws 2020 guidance amid lower commercial truck production in North America and plant shutdowns by various OEMs in Europe.
Cooper Tire Shuts US Manufacturing Plants on Coronavirus Scare
by Zacks Equity Research
Cooper Tire (CTB) production halt at its plants will proceed on a rolling schedule over the coming week, with facilities expected to be closed for two to three weeks.